[1]
Z. A. Mohammed, “Neuroimmunological Shifts in Disease-Modifying Therapy Use Among Multiple Sclerosis Patients: A Regional Study from Sulaymaniyah, Iraq”, Al-Rafidain J Med Sci, vol. 11, no. 2, pp. 293–297, Nov. 2026.